Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: NSK Co., Ltd. and Cyfuse Co., Ltd. succeeded in developing new technology for automating product manufacturing processes in the field of regenerative and cell medicine
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Notice regarding business adoption for the Reiwa 6 New Product/New Technology Development Grant Project
Cyfuse Biomedical KK: New technology development through collaboration in the field of regeneration and cell therapy by Iwaya Sangyo Co., Ltd. and Saifuse Co., Ltd.
Cyfuse Biomedical KK: Announcements of individual stocks related to the adoption of the grant for improving productivity in manufacturing, commerce, and service.
CYFUSE BIOMEDICAL K K: Notice regarding adoption and participation in the AMED public offering project “Bridging Research Program”
Cyfuse Biomedical KK: Matters relating to business plans and growth potential
Cyfuse: Notice regarding the recording of non-operating income
Cyfuse: World's First 3D Neural Conduit Transplantation for Peripheral Nerve Injury - Doctor-Led Clinical Trial Results and Toward Social Implementation
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Concluded a basic agreement on a business partnership
Cyfuse Biomedical KK: Notice regarding participation in the AMED public offering project “Regeneration/Cell Medicine/Gene Therapy Realization Acceleration Program”
Cyfuse Biomedical KK: Notice Concerning the Recording of Non-Operating Profit
Cyfuse Biomedical KK: Results of physician-led clinical trials of three-dimensional neural conduit transplantation
Cyfuse Biomedical KK: Matters relating to business plans and growth potential
Cyfuse Biomedical KK: Articles of Incorporation 2023/03/28
Cyfuse Biomedical KK: To conclude a basic agreement on cooperation for the purpose of developing regenerative medicine.
Cyfuse Biomedical KK: Notice on the Stock Remuneration system with transfer restrictions on Directors
No Data
No Data